Gemmer Asset Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-25
Closed -$3K 1537
2020
Q4
$3K Hold
25
﹤0.01% 1294
2020
Q3
$2K Hold
25
﹤0.01% 1256
2020
Q2
$3K Sell
25
-25
-50% -$2.84K ﹤0.01% 1113
2020
Q1
$4K Hold
50
﹤0.01% 894
2019
Q4
$5K Buy
+50
New +$5.61K ﹤0.01% 999
2018
Q1
Sell
-120
Closed -$16K 1516
2017
Q4
$16K Hold
120
0.01% 529
2017
Q3
$12K Buy
+120
New +$12.9K ﹤0.01% 602

Other funds holding GWPH

Gemmer Asset Management's GWPH Position: Q1 2021 in Review

Gemmer Asset Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2021, closing a stake of 25 shares — an estimated $3K sold.

Gemmer Asset Management first reported a position in GWPH in Q3 2017 and held it in 7 quarters. The position peaked at $16K in Q4 2017. 297 funds tracked by Wall St. Rank hold GWPH as of Q1 2021.

  • Gemmer Asset Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2021 after selling out during the quarter.
  • Gemmer Asset Management sold 25 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2021, an estimated $3K.
  • Gemmer Asset Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2017 and held it in 7 quarters.
  • Gemmer Asset Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $16K in Q4 2017.
  • 297 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2021.

Based on Gemmer Asset Management's 13F filing for Q1 2021, filed 20 Apr 2021.